Tiziana Life Sciences Ltd.: Tiziana Life Sciences Announces

The second Expanded Access patient (EA2) demonstrated improved walking as measured by gait stability and enduranceThe patient showed clinically significant improvement in the Expanded Disability Status

Related Keywords

, Irina Koffler , Hana Malik , Howardl Weiner , Gabriele Cerrone , Tanuja Chitnis , Tiziana Life Sciences , Lifesci Advisors , Tiziana Life Sciences Ltd , Ann Romney Center , Nasdaq , Business Development , Expanded Access , Expanded Disability Status Scale , Life Sciences , Executive Chairman , Chief Executive Officer , Neurologic Diseases , Scientific Advisory Board , Investor Relations , Sci Advisors , Tiziana , Life , Ciences , Nnounces , Ontinued , Linical , Improvements , Second , Patient , Secondary , Progressive , Multiple , Clerosis , Pms , After , Months , Closing , Intranasal , Foralumab ,